About me
Rose Loughlin, Ph.D., currently serves as Senior Vice President of Research and Development at Moderna, where she has played a crucial role in advancing the company's mRNA platform since joining in 2016. In her current role, she focuses on shaping Moderna’s portfolio and platform strategy. Before joining Moderna, Rose gained valuable experience at Biogen in business development and at L.E.K. Consulting, where she contributed to defining corporate and portfolio growth strategies for biopharmaceuticals. Rose holds a Ph.D. in Biophysics from the University of California, Berkeley, and a bachelor's degree in physics from Harvard University.